Citations

Clear

4801 citation(s) found for "Yu, Jennifer".

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study
Cull, Gavin , Burger, Jan A. , Opat, Stephen , Gottlieb, David , Verner, Emma , Marlton, Paula , Johnston, Patrick, Simpson, David , Prathikanti, Radha, Wu, Kenneth, Novotny, William , Huang, Jane , Tam, Constantine S , Burger, Jan A , Opat, Stephen , Trotman, Judith , Muñoz, Javier , Stern, Jennifer C., Tam, Constantine S.

Mayo Clinic

British Journal of Haematology | December 16, 2021 | Volume: 196 | Issue: 5 | Pages: 1209-1218

10.1111/bjh.17994 | PMID 34915592 Get It

SummaryThe phase I/II AU‐003 study in patients with treatment‐naïve (TN) or relapsed/refractory (R/R) chronic lymphocytic leukaemia/small lymphocytic lymphoma demonstrated that zanubrutinib therapy results in clinically meaningful and durable responses with acceptable safety and tolerability. We report updated safety and efficacy data for 123 patients with a median follow‐up of 47·2 months. Patients received zanubrutinib 160 mg twice daily (81 patients), 320 mg once daily (40), or 160 mg once daily (two). Discontinuations due to adverse events or disease progression were uncommon. The overall response rate (ORR) was 95·9% (TN, 100%; R/R, 95%) with 18·7% achieving complete response (CR). Ongoing response at 3 years was reported in 85·7%. The ORR in patients with del(17p)/tumour protein p53 mutation was 87·5% (CR 16·7%). The 2‐ and 3‐year progression‐free survival estimates were 90% (TN, 90%; R/R, 91%) and 83% (TN, 81%; R/R, 83%) respectively. The most reported Grade ≥3 adverse events were neutropenia (15·4%), pneumonia (9·8%), hypertension (8·9%) and anaemia (6·5%). The annual incidence of atrial fibrillation, major haemorrhage, Grade ≥3 neutropenia and Grade ≥3 infection decreased over time. With a median follow‐up of ~4 years, responses remain clinically meaningful and durable and long‐term tolerability to zanubrutinib therapy continues.
773: INCIDENCE AND PREDICTIVE FACTORS ASSOCIATED WITH BETA-LACTAM NEUROTOXICITY IN THE CRITICALLY ILL
Haddad, Natalie A., Schreier, Diana J., Fugate, Jennifer E. , Hocker, Sara E. , Ice, Calvin , Leung, Sarah, Frazee, Erin N. , Gajic, Ognjen , Mara, Kristin C. , Rabinstein, Alejandro A. , Rule, Andrew D.

Mayo Clinic

Critical Care Medicine | December 16, 2021 | Volume: 50 | Issue: 1 | Pages: 381-381

10.1097/01.ccm.0000809416.80809.1d Get It

Cervical Alignment and Proximal and Distal Junctional Failure in Posterior Cervical Fusion
Monsef, Jad Bou , Mao, Jennifer Z. , Xiong, Ashley , Bowles, Daniel R. , Conaway, William K. , Reiter, David M, Honig, Rachel , Currier, Bradford L. , Freedman, Brett A. , Bydon, Mohamad , Elder, Benjamin D. , Kaye, I. David , Kepler, Christopher K. , Schroeder, Gregory D. , Wagner, Scott C. , Sebastian, Arjun S. , Bou Monsef, Jad, Pinter, Zachariah W. , Karamian, Brian A. , Reiter, David M, Nassr, Ahmad , Vaccaro, Alexander R.

Mayo Clinic

Clinical Spine Surgery | December 15, 2021 | Volume: 35 | Issue: 5 | Pages: E451-E456

10.1097/bsd.0000000000001281 | PMID 34907934 Get It

Study Design: This was a multicenter retrospective cohort study. Objective: The purpose of this study was to compare the surgical and radiographic outcomes of patients undergoing posterior cervical fusion (PCF) with constructs extending from C2 to T2 to patients with constructs extending from C3 to T1. Summary of Background Data: Limited evidence exists regarding the appropriate level of proximal and distal extension of PCF constructs. Methods: A multicenter retrospective cohort study of patients who underwent PCF between 2012 and 2020 was performed. Surgical and radiographic outcomes were compared between those who had C3–T1 or C2–T2 constructs. Results: A total of 155 patients were included in the study (C2–T2: 106 patients, C3–T1: 49 patients). There were no significant differences in demographics or preoperative symptoms between cohorts. Fusion rates were significantly higher in the C2–T2 (93%) than the C3–T1 (80%, P=0.040) cohort. When comparing the C2–T2 to the C3–T1 cohort, the C3–T1 cohort had a significantly greater rate of proximal junctional failure (2% vs. 10%, P=0.006), distal junctional failure (1% vs. 20%, P<0.001) and distal screw loosening (4% vs. 15%, P=0.02). Although ∆C2–C7 sagittal vertical axis increased significantly in both cohorts (C2–T2: 6.2 mm, P=0.04; C3–T1: 8.4 mm, P<0.001), correction did not significantly differ between groups (P=0.32). The C3–T1 cohort had a significantly greater increase in ∆C2 slope (8.0 vs. 3.1 degrees, P=0.03) and ∆C0–C2 Cobb angle (6.4 vs. 1.2 degrees, P=0.04). Conclusion: In patients undergoing PCF, a C2–T2 construct demonstrated lower rates of pseudarthrosis, distal junctional failure, proximal junctional failure, and compensatory upper cervical hyperextension compared with a C3–T1 construct.
Association of Neurological Impairment on the Relative Benefit of Maximal Extent of Resection in Chemoradiation-Treated Newly Diagnosed Isocitrate Dehydrogenase Wild-Type Glioblastoma
Aabedi, Alexander A. , Young, Jacob S., Zhang, Yalan, Ammanuel, Simon, Morshed, Ramin A., Ore, Cecilia Dalle, Brown, Desmond, Phillips, Joanna J., Bush, Nancy Ann Oberheim, Taylor, Jennie W., Butowski, Nicholas, Clarke, Jennifer, Chang, Susan M., Aghi, Manish, Molinaro, Annette M., Berger, Mitchel S., Hervey-Jumper, Shawn L., Clarke, Jennifer , Morshed, Ramin A. , Morshed, Ramin , Aabedi, Alexander A. , Young, Jacob S., Zhang, Yalan, Ammanuel, Simon, Morshed, Ramin A., Ore, Cecilia Dalle, Brown, Desmond, Phillips, Joanna J., Bush, Nancy Ann Oberheim, Taylor, Jennie W., Butowski, Nicholas, Clarke, Jennifer, Chang, Susan M., Aghi, Manish, Molinaro, Annette M., Berger, Mitchel S., Hervey-Jumper, Shawn L.

Mayo Clinic

Neurosurgery | December 15, 2021 | Volume: 90 | Issue: 1 | Pages: 124-130

10.1227/neu.0000000000001753 | PMID 34982879 Get It

BACKGROUND: Increases in the extent of resection of both contrast-enhanced (CE) and non–contrast-enhanced (NCE) tissue are associated with substantial survival benefits in patients with isocitrate dehydrogenase wild-type glioblastoma. The fact, however, remains that these lesions exist within the framework of complex neural circuitry subserving cognition, movement, and behavior, all of which affect the ultimate survival outcome. The prognostic significance of the interplay between CE and NCE cytoreduction and neurological morbidity is poorly understood. OBJECTIVE: To identify a clinically homogenous population of 228 patients with newly diagnosed isocitrate dehydrogenase wild-type glioblastoma, all of whom underwent maximal safe resection of CE and NCE tissue and adjuvant chemoradiation. We then set out to delineate the competing interactions between resection of CE and NCE tissue and postoperative neurological impairment with respect to overall survival. METHODS: Nonparametric multivariate models of survival were generated via recursive partitioning to provide a clinically intuitive framework for the prognostication and surgical management of such patients. RESULTS: We demonstrated that the presence of a new postoperative neurological impairment was the key factor in predicting survival outcomes across the entire cohort. Patients older than 60 yr who suffered from at least one new impairment had the worst survival outcome regardless of extent of resection (median of 11.6 mo), whereas those who did not develop a new impairment had the best outcome (median of 28.4 mo) so long as all CE tissue was resected. CONCLUSION: Our data provide novel evidence for management strategies that prioritize safe and complete resection of CE tissue.
UME-to-GME PandEMonium in COVID-19: Large-Scale Implementation of a Virtual ACGME Milestone-Based Curriculum for Senior Medical Students Matched Into Emergency Medicine
McLean, Mary E., Cotarelo, Adrian A., Huls, Thomas A., Husain, Abbas, Hillman, Emily A., Cygan, Lukasz D., Archer, Linette O., Beck-Esmay, Jennifer, Burke, Shannon M., Carrick, Angela I., Chen, Angela S., Hyde, Robert J., Karalius, Vytas P., Lee, Eric, Park, Joel C., Pugliese, Angela M., Wilbanks, Morgan D., Young, Amanda, Kulkarni, Miriam L., Karalius, Vytas P. , Husain, Abbas , McLean, Mary E., Cotarelo, Adrian A., Huls, Thomas A., Husain, Abbas, Hillman, Emily A., Cygan, Lukasz D., Archer, Linette O., Beck-Esmay, Jennifer, Burke, Shannon M., Carrick, Angela I., Chen, Angela S., Hyde, Robert J., Lee, Eric, Park, Joel C., Pugliese, Angela M., Wilbanks, Morgan D., Young, Amanda, Kulkarni, Miriam L.

Mayo Clinic

Journal of Graduate Medical Education | December 14, 2021 | Volume: 13 | Issue: 6 | Pages: 848-857

10.4300/jgme-d-21-00620.1 | PMID 35070098 Get It

ABSTRACT Background The COVID-19 pandemic displaced newly matched emergency medicine “pre-interns” from in-person educational experiences at the end of medical school. This called for novel remote teaching modalities. Objective This study assesses effectiveness of a multisite Accreditation Council for Graduate Medical Education (ACGME) sub-competency-based curricular implementation on Slack during the first wave of the COVID-19 pandemic in the United States. Methods Emergency medicine residency programs were recruited via national organization listservs. Programs designated instructors to manage communications and teaching for the senior medical students who had matched to their programs (pre-interns) in spring/summer 2020. Pre- and post-surveys of trainees and instructors assessed perceived preparedness for residency, perceived effectiveness of common virtual educational modalities, and concern for the pandemic's effects on medical education utilizing a Likert scale of 1 (very unconcerned) to 5 (very concerned). Data were analyzed using descriptive statistics and the t test. Results Of 276 possible residency programs, 28 enrolled. Of 324 possible pre-interns, 297 (91.7%) completed pre-surveys in April/May and 249 (76.9%) completed post-surveys in June/July. The median weeks since performing a physical examination was 8 (IQR 7–12), since attending in-person didactics was 10 (IQR 8–15) and of rotation displacement was 4 (IQR 2–6). Perceived preparedness increased both overall and for 14 of 21 ACGME Milestone topics taught. Instructors reported higher mean concern (4.32, 95% CI 4.23–4.41) than pre-interns (2.88, 95% CI 2.74–3.02) regarding the pandemic's negative effects on medical education. Conclusions Pre-interns reported improvements in residency preparedness after participating in this ACGME sub-competency-based curriculum on Slack.
Behavioral and Physiologic Effects of Dirty Bedding Exposure in Female ICR Mice
Merley, Anne L, Hubbard, Jennifer, Rendahl, Aaron , Boynton, Felicia D. Duke , Impelluso, Lynn Collura, Duke Boynton, Felicia D

Mayo Clinic

Journal of the American Association for Laboratory Animal Science | December 14, 2021 | Volume: 61 | Issue: 1 | Pages: 42-51

10.30802/aalas-jaalas-21-000060 | PMID 34903313 Get It

Exposure of sentinel mice to dirty bedding is commonly used in health monitoring programs to screen colonies for clinical and subclinical disease. Despite the potential stressors present in dirty bedding, including but not limited to microorganisms, pheromones, and ammonia, it is unknown whether sentinel mice exposed to soiled bedding experience stress. In this study, select behavioral and physiologic changes associated with stress were assessed in female ICR mice exposed to dirty bedding. Behavioral parameters included evaluation in the home cage and selected behavioral tests; physiologic measurements included neutrophil:lymphocyte ratio and weight. Mice in the acute group were exposed for 24 h whereas mice in the chronic group were exposed for 4 wk. Mice in the chronic group exposed to dirty bedding weighed less at days 21 and 28 than did control mice. Chronic mice exposed to dirty bedding also exhibited decreased net weight gain over the entire study period as compared with control mice. No significant differences were detected in the other behavioral and physiologic parameters measured. These results indicate that dirty bedding exposure may affect sentinel mice, but further investigation is needed to determine the specific mechanism(s) behind the weight difference.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8
Heinze, Karolin , Nazeran, Tayyebeh M., Lee, Sandra , Krämer, Pauline , Leung, Samuel , Kang, Eun Young , Meagher, Nicola S. , Kennedy, Catherine J. , Boros, Jessica , Kommoss, Friedrich, Vollert, Hans‐Walter, Harter, Philipp , Kraemer, Bernhard , Staebler, Annette , Heublein, Sabine , Sinn, Hans‐Peter , Singh, Naveena , Laslavic, Angela , Olawaiye, Alex, Moysich, Kirsten B. , Sharma, Raghwa , Brand, Alison H. , Harnett, Paul R. , DeFazio, Anna , Fortner, Renée T. , Lener, Marcin , Tołoczko‐Grabarek, Aleksandra, Coulson, Penny , El‐Bahrawy, Mona , Jones, Michael E. , Schoemaker, Minouk J. , Gayther, Simon A. , Carney, Michael E. , Shvetsov, Yurii B. , Hernandez, Brenda Y. , Goodman, Marc T. , Mateoiu, Constantina , Linder, Anna , Kelemen, Linda E. , Widschwendter, Martin , Menon, Usha , Alsop, Jennifer , Shah, Mitul , Jimenez‐Liñan, Mercedes , Brenton, James D. , Cushing‐Haugen, Kara L. , Huntsman, David G. , Nelson, Gregg , Tinker, Anna V. , Goode, Ellen L. , Ramus, Susan J. , Kommoss, Stefan , Talhouk, Aline , Köbel, Martin , Anglesio, Michael S. , Campbell, Ian G , Gilks, C. Blake , Köbel, Martin , Anglesio, Michael S , Fazio, Anna de , Fortner, Renée T , Ramus, Susan J , Menon, Usha , Brenton, James D , Moysich, Kirsten , Kennedy, Catherine J , Sinn, Peter , Widschwendter, Martin , Jones, Michael E , Brand, Alison H , Nelson, Gregg S , El-Bahrawy, Mona A , Harnett, Paul R , Hernandez, Brenda Y , Schoemaker, Minouk J , Goodman, Marc T , Linder, Anna , Cairns, Evan S. , Chiu, Derek S , Heitz, Florian , Bois, Andreas du , Grube, Marcel , Kommoss, Felix , Elishaev, Esther , Modugno, Francesmary , Lubiński, Jan , Cybulski, Cezary , Gronwald, Helena , Gronwald, Jacek , Swerdlow, Anthony J. , Gorringe, Kylie L. , Campbell, Ian , Cook, Linda S. , Wilkens, Lynne R. , Sundfeldt, Karin , Gentry‐Maharaj, Aleksandra , Bolton, Kelly L. , Pharoah, Paul D.P. , Harris, Holly R. , Doherty, Jennifer A. , Ghatage, Prafull , Lee, Cheng‐Han , Nelson, Brad H.

Mayo Clinic

The Journal of Pathology | December 13, 2021 | Volume: 256 | Issue: 4 | Pages: 388-401

10.1002/path.5849 | PMID 34897700 Get It

Abstract ARID1A (BAF250a) is a component of the SWI/SNF chromatin modifying complex, plays an important tumour suppressor role, and is considered prognostic in several malignancies. However, in ovarian carcinomas there are contradictory reports on its relationship to outcome, immune response, and correlation with clinicopathological features. We assembled a series of 1623 endometriosis‐associated ovarian carcinomas, including 1078 endometrioid (ENOC) and 545 clear cell (CCOC) ovarian carcinomas, through combining resources of the Ovarian Tumor Tissue Analysis (OTTA) Consortium, the Canadian Ovarian Unified Experimental Resource (COEUR), local, and collaborative networks. Validated immunohistochemical surrogate assays for ARID1A mutations were applied to all samples. We investigated associations between ARID1A loss/mutation, clinical features, outcome, CD8 + tumour‐infiltrating lymphocytes (CD8 + TILs), and DNA mismatch repair deficiency (MMRd). ARID1A loss was observed in 42% of CCOCs and 25% of ENOCs. We found no associations between ARID1A loss and outcomes, stage, age, or CD8 + TIL status in CCOC. Similarly, we found no association with outcome or stage in endometrioid cases. In ENOC, ARID1A loss was more prevalent in younger patients ( p = 0.012) and was associated with MMRd ( p < 0.001) and the presence of CD8 + TILs ( p = 0.008). Consistent with MMRd being causative of ARID1A mutations, in a subset of ENOCs we also observed an association with ARID1A loss‐of‐function mutation as a result of small indels ( p = 0.035, versus single nucleotide variants). In ENOC, the association with ARID1A loss, CD8 + TILs, and age appears confounded by MMRd status. Although this observation does not explicitly rule out a role for ARID1A influence on CD8 + TIL infiltration in ENOC, given current knowledge regarding MMRd, it seems more likely that effects are dominated by the hypermutation phenotype. This large dataset with consistently applied biomarker assessment now provides a benchmark for the prevalence of ARID1A loss‐of‐function mutations in endometriosis‐associated ovarian cancers and brings clarity to the prognostic significance. © 2021 The Pathological Society of Great Britain and Ireland.
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories
Miller, W. Greg , Kaufman, Harvey W. , Levey, Andrew S. , Straseski, Joely A., Wilhelms, Kelly W. , Yu, Hoi Ying, Klutts, J. Stacey , Horowitz, Gary L., Lieske, John C. , Ennis, Jennifer, Bowling, James L., Lewis, M. J. T., Inker, Lesley A. , Lieske, John C , Hilborne, Lee H. , Lewis, Mary Jane, Montgomery, Elizabeth, Vassalotti, Joseph A.

Mayo Clinic

Clinical Chemistry | December 11, 2021 | Volume: 68 | Issue: 4 | Pages: 511-520

10.1093/clinchem/hvab278 | PMID 34918062 Get It

Abstract Recognizing that race is a social and not a biological construct, healthcare professionals and the public have called for removal of race in clinical algorithms. In response, the National Kidney Foundation and the American Society of Nephrology created the Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases to examine the issue and provide recommendations. The final report from the Task Force recommends calculating estimated glomerular filtration rate (eGFR) without a race coefficient using the recently published CKD-EPI 2021 creatinine (cr) and creatinine-cystatin C (cr-cys) equations. The Task Force recommends immediately replacing older eGFRcr equations (MDRD Study and CKD-EPI 2009) with the new CKD-EPI 2021 equation. In a 2019 survey by the College of American Pathologists, 23% of 6200 laboratories reporting eGFRcr used an incorrect equation that is not suitable for use with standardized creatinine measurements, 34% used the CKD-EPI 2009 equation and 43% used the MDRD Study 2006 equation re-expressed for standardized creatinine measurement. Rapid transition to using the CKD-EPI 2021 equation is an opportunity for laboratories to standardize to a single equation to eliminate differences in eGFRcr due to different equations used by different laboratories, and to report eGFR without use of race. We provide guidance to laboratories for implementing the CKD-EPI 2021 equations for both eGFRcr and eGFRcr-cys.
Development and evaluation of IL‐6 overexpressing mesenchymal stem cells (MSCs)
Huang, Peng , Zhang, Cuiping , Delawary, Mina, Korchak, Jennifer A. , Suda, Koji, Zubair, Abba C.

Mayo Clinic

Journal of Tissue Engineering and Regenerative Medicine | December 10, 2021 | Volume: 16 | Issue: 3 | Pages: 244-253

10.1002/term.3274 | PMID 34890489 Get It

Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma
Porter, Alyx B. , Liu, Heshan , Kohli, Sadhna , Cerhan, Jane, Sloan, Jeff A. , Loprinzi, Charles L. , Kizilbash, Sani H. , Jaeckle, Kurt A. , Brown, Paul D. , Cerhan, Jane L, McMurray, Ryan P. , Kizilbash, Sani H , Le‐Rademacher, Jennifer , Villano, John L. , Mehta, Minesh P.

Mayo Clinic

JAMA Oncology | December 9, 2021 | Volume: 8 | Issue: 2 | Pages: 259

10.1001/jamaoncol.2021.5948 | PMID 34882169 Get It